CRO belong to the pharmaceutical Company (CRO b2Ph [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-07-09 00:18 (649 d 22:55 ago) – Posting: # 23120
Views: 2,102

Hi Captian ElMaestro, Helmut & all,

Should I understand that you think these kinds of studies "performed in CRO belong to the pharmaceutical Company" should be blocked and not accepted due to the high risk of COI and the possibility of manipulating the studies' outcomes.
Is there any guidance, or literature on which we can rely on it to regulate this issue?
Please kindly express your opinion clearly and frankly, it will help a lot.

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,669 registered users;
53 visitors (0 registered, 53 guests [including 4 identified bots]).
Forum time: 23:13 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5